DawMed Systems PLC
12 December 2003
Embargoed until 07.30 hours on Friday 12 December 2003
DAWMED SYSYTEMS PLC ('DawMed' or 'Company')
Fund Raising
DawMed has agreed to issue a total of 2,400,000 new Ordinary Shares of 5p each
to institutional and other investors at a price of 22.5p per share, raising a
total of £540,000 (before expenses). The proceeds of the issue will be used for
the prime purpose of further expanding the marketing and sales of the new DawMed
'Clinic' bench-top washer disinfector and the support services department, but
also to provide additional working capital.
The new Ordinary Shares will rank pari passu with the existing Ordinary Shares
in issue and application will be made for the new Ordinary Shares to be admitted
to trading on the Alternative Investment Market.
The new Ordinary Shares are being issued as follows:
Subscriber Number
Hoodless Brennan & Partners PLC 1,000,000
Phoenix VCT PLC 450,000
The Bioscience VCT PLC 450,000
City Equities Limited 500,000
________
Total 2,400,000
12 December 2003
For information:
Kevin Gilmore 01789 450075
Roland Cornish (Beaumont Cornish Limited) 0207 628 3396
Rosie Brown (Tavistock Communications) 0207 020 3150
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.